CL
ABBV icon

CLG LLC’s AbbVie ABBV Stock Holding History

CLG LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
2,971
+11
+0.4% +$2.37K 0.16% 74
2026
Q1 		$644K Buy
2,960
+10
+0.3% +$2.22K 0.16% 75
2025
Q4 		$674K Sell
2,950
-11
-0.4% -$2.51K 0.17% 69
2025
Q3 		$686K Buy
2,961
+11
+0.4% +$2.24K 0.19% 68
2025
Q2 		$548K Buy
2,950
+12
+0.4% +$2.23K 0.17% 79
2025
Q1 		$616K Buy
2,938
+11
+0.4% +$2.14K 0.21% 66
2024
Q4 		$520K Buy
+2,927
New +$538K 0.19% 74

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

CLG LLC's ABBV Position: Q2 2026 in Review

CLG LLC increased its AbbVie (ABBV) stake by 0.37% in Q2 2026, buying an estimated $2.37K and bringing the position to 2,971 shares worth $748K. The position accounts for 0.16% of the portfolio, ranked #74.

CLG LLC first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CLG LLC held 2,971 shares of AbbVie worth $748K as of Q2 2026.
  • CLG LLC bought 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.16% of CLG LLC's portfolio in Q2 2026, its #74 holding.
  • CLG LLC first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CLG LLC's 13F filing for Q2 2026, filed 16 Jul 2026.